CL
AKBA icon

Choreo LLC’s Akebia Therapeutics AKBA Stock Holding History

Choreo LLC’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$641K Buy
+562,423
New +$670K 0.01% 854

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Choreo LLC's AKBA Position: Q2 2026 in Review

Choreo LLC opened a new position in Akebia Therapeutics (AKBA) in Q2 2026: 562,423 shares worth $641K. The stake represents 0.01% of the portfolio and ranks #854 among its holdings.

60 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Choreo LLC held 562,423 shares of Akebia Therapeutics worth $641K as of Q2 2026.
  • Akebia Therapeutics was a new Choreo LLC position in Q2 2026.
  • Akebia Therapeutics made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #854 holding.
  • 60 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.